ACTIVE

PHARMASOVA

Export PDF

Financial year 2025 · closed on 30/06/2025

Net result

1,9 M €

+25.0% YoY

Gross margin

82,8 k €

-10.8% YoY

Equity

27,9 M €

+0.4% YoY

What does PHARMASOVA do?

PHARMASOVA is a Public limited company incorporated in 2003. Its main activity is: Activities of holding companies. Its registered office is in Anderlecht.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0864.058.578

Incorporation

30/06/2003

Legal form

Public limited company

Registered office

Avenue René Berrewaerts 16
1070 Anderlecht · BruxellesSee on map

Contributed capital

6 337 309,23 €

Latest accounts

30/06/2025

Activities (NACE)

64200Activities of holding companies· main 64210Activities of holding companies 74151Specialised design activities

Signals

ProfitableSolid equityLow riskPositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 19 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007
Income statement
Gross margin	82,8 k €	-10.8%	92,8 k €	+10.9%	83,7 k €	-17.5%	101,5 k €	-21.9%	130 k €	-23.4%	169,6 k €	+38.0%	122,9 k €	-19.4%	152,5 k €	+58.1%	96,4 k €	+115%	44,8 k €	-29.2%	63,2 k €	-27.8%	87,6 k €	-8.8%	96,1 k €	+46.4%	65,6 k €	+45.5%	45,1 k €	+42.5%	31,7 k €	+272%	8,5 k €	-34.5%	13 k €	-27.8%	18 k €
EBITDA	81,5 k €	-11.3%	91,9 k €	+10.8%	82,9 k €	-17.6%	100,6 k €	-14.4%	117,5 k €	-24.9%	156,4 k €	+42.2%	110 k €	-7.1%	118,4 k €	+35.0%	87,7 k €	+171%	32,4 k €	-10.8%	36,3 k €	-7.6%	39,3 k €	-58.6%	95,1 k €	+49.1%	63,8 k €	+44.5%	44,1 k €	+79.5%	24,6 k €	+189%	8,5 k €	-34.5%	13 k €	-27.8%	18 k €
Operating result	81,5 k €	-11.3%	91,9 k €	+10.8%	82,9 k €	-17.6%	100,6 k €	+11.9%	89,9 k €	-11.2%	101,2 k €	+84.9%	54,7 k €	-25.2%	73,2 k €	+72.2%	42,5 k €	+31.1%	32,4 k €	-10.8%	36,3 k €	-7.6%	39,3 k €	-58.6%	95,1 k €	+49.1%	63,8 k €	+44.5%	44,1 k €	+79.5%	24,6 k €	+189%	8,5 k €	-34.5%	13 k €	-27.8%	18 k €
Net result	1,9 M €	+25.0%	1,5 M €	+308%	363 k €	-90.8%	3,9 M €	-79.4%	19,1 M €	+4812%	388 k €	-10.1%	431,7 k €	+41.9%	304,3 k €	-15.8%	361,3 k €	+18.0%	306,3 k €	+15.7%	264,7 k €	+1.3%	261,4 k €	-30.0%	373,3 k €	+20.9%	308,6 k €	+35.5%	227,8 k €	+1173%	17,9 k €	-91.4%	207,7 k €	-1.5%	210,8 k €	+1033%	18,6 k €
Balance sheet
Equity	27,9 M €	+0.4%	27,8 M €	+0.3%	27,7 M €	+0.1%	27,7 M €	+9.2%	25,4 M €	+217%	8 M €	+5.1%	7,6 M €	+6.0%	7,2 M €	+4.4%	6,9 M €	+46.0%	4,7 M €	+6.9%	4,4 M €	+6.4%	4,2 M €	+6.7%	3,9 M €	+10.6%	3,5 M €	+9.6%	3,2 M €	+7.6%	3 M €	+0.6%	3 M €	+7.5%	2,8 M €	+8.3%	2,5 M €
Total assets	38,9 M €	-0.3%	39,1 M €	-3.4%	40,4 M €	-0.2%	40,5 M €	+4.6%	38,7 M €	+226%	11,9 M €	-0.8%	12 M €	+2.3%	11,7 M €	+0.2%	11,7 M €	+15.6%	10,1 M €	+79.4%	5,6 M €	+3.4%	5,5 M €	-7.5%	5,9 M €	+8.0%	5,5 M €	+4.6%	5,2 M €	+1.2%	5,2 M €	-3.0%	5,3 M €	+4.3%	5,1 M €	+4.4%	4,9 M €
Cash	89,8 k €	-48.4%	174 k €	-0.7%	175,3 k €	-79.2%	842,1 k €	+334%	194 k €	-75.7%	799,4 k €	-5.8%	848,9 k €	+33.1%	637,7 k €	+3.5%	616,2 k €	-27.4%	848,3 k €	+8.0%	785,4 k €	+3.2%	760,9 k €	-15.0%	895,7 k €	+43.5%	624,3 k €		–		662,2 k €	+3.0%	642,9 k €	+58.6%	405,3 k €	-0.8%	408,4 k €
Debts	11 M €	-2.0%	11,2 M €	-11.5%	12,7 M €	-0.9%	12,8 M €	-4.0%	13,3 M €	+245%	3,9 M €	-11.2%	4,4 M €	-3.6%	4,5 M €	-5.9%	4,8 M €	-11.1%	5,4 M €	+342%	1,2 M €	-6.2%	1,3 M €	-35.1%	2 M €	+3.3%	1,9 M €	-3.5%	2 M €	-7.6%	2,2 M €	-7.5%	2,4 M €	+0.5%	2,3 M €	+0.3%	2,3 M €

Estimate

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€

See the valuation

Governance

Board of directors

Seen on filing of 30/06/2025 · 3 active · 6 ended

Active mandates

Daniel CATOUL

Director · since 05 mars 2021

Active

E2A Partners

Managing director · since 05 mars 2021 · 0750.529.085

Represented by Sophie EYKERMAN

Active

Rita LABIS

Director · since 05 février 2021

Active

Ended mandates

Daniel CATOUL

Director · since 05 avril 2021

Ended

E2A Partners

Managing director · since 05 avril 2021 · 0750.529.085

Represented by Sophie EYKERMAN

Ended

E2A Partners

Managing director · since 05 avril 2021 · 0750.529.085

Represented by Sophie EYKERMAN

Ended

Rita ²LABIS

Director · since 05 mars 2021

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/07/2024	01/07/2023	01/07/2022	01/07/2021	01/07/2020	01/07/2019
Closing of the financial year	30/06/2025	30/06/2024	30/06/2023	30/06/2022	30/06/2021	30/06/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	30/01/2026	10/02/2025	06/02/2024	01/03/2023	09/02/2022	31/12/2020
General meeting	01/12/2025	02/12/2024	04/12/2023	05/12/2022	07/02/2022	27/12/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	30/06/2025	01/12/2025	30/01/2026	French	PDF
Abridged model	30/06/2024	02/12/2024	10/02/2025	French	PDF
Abridged model	30/06/2023	04/12/2023	06/02/2024	French	PDF
Abridged model	30/06/2022	05/12/2022	01/03/2023	French	PDF
Abridged model	30/06/2021	07/02/2022	09/02/2022	French	PDF
Abridged model	30/06/2020	27/12/2020	31/12/2020	French	PDF
Abridged model	30/06/2019	27/12/2019	20/01/2020	French	PDF
Abridged model	30/06/2018	27/12/2018	28/12/2018	French	PDF
Micro model	30/06/2017	25/12/2017	30/01/2018	French	PDF
Abridged model	30/06/2016	25/12/2016	30/12/2016	French	PDF
Abridged model	30/06/2015	22/12/2015	22/12/2015	French	PDF
Abridged model	30/06/2014	31/01/2015	29/04/2015	French	PDF
Abridged model	30/06/2013	27/12/2013	27/12/2013	French	PDF
Abridged model	30/06/2012	30/12/2012	23/09/2013	French	PDF
Abridged model	30/06/2011	27/04/2012	03/05/2012	French	PDF
Abridged model	30/06/2010	06/12/2010	01/03/2011	French	PDF
Abridged model	30/06/2009	07/12/2009	28/01/2010	French	PDF
Abridged model	30/06/2008	01/12/2008	20/01/2009	French	PDF
Abridged model	30/06/2007	03/12/2007	26/02/2008	French	PDF
Abridged model	30/06/2006	04/12/2006	22/01/2007	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 30/06/2025 · 3 active · 6 ended

Active mandates

Daniel CATOUL

Director · since 05 mars 2021

Active

E2A Partners

Managing director · since 05 mars 2021 · 0750.529.085

Represented by Sophie EYKERMAN

Active

Rita LABIS

Director · since 05 février 2021

Active

Ended mandates

Daniel CATOUL

Director · since 05 avril 2021

Ended

E2A Partners

Managing director · since 05 avril 2021 · 0750.529.085

Represented by Sophie EYKERMAN

Ended

E2A Partners

Managing director · since 05 avril 2021 · 0750.529.085

Represented by Sophie EYKERMAN

Ended

Rita ²LABIS

Director · since 05 mars 2021

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Restructuring29/07/2021
CAPITAL, ACTIONS - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
PDF
Mandates28/04/2021
DEMISSIONS, NOMINATIONS
PDF
Mandates08/04/2021
DEMISSIONS, NOMINATIONS
PDF
Restructuring30/03/2021
RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...) - DIVERS
PDF
Mandates10/02/2021
MODIFICATION FORME JURIDIQUE - DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates07/08/2017
DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Capital / shares22/11/2016
CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Other21/01/2014
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 20251,9 M €↑
2024
Annual accounts 20241,5 M €↑
2023
Annual accounts 2023363 k €↓
2022
Annual accounts 20223,9 M €↓
2021
Annual accounts 202119,1 M €↑
2020
Annual accounts 2020388 k €↓
2019
Annual accounts 2019431,7 k €↑
2018
Annual accounts 2018304,3 k €↓
2017
Annual accounts 2017361,3 k €↑
2016
Annual accounts 2016306,3 k €↑
2015
Annual accounts 2015264,7 k €↑
2014
Annual accounts 2014261,4 k €↓
2013
Annual accounts 2013373,3 k €↑
2012
Annual accounts 2012308,6 k €↑
2011
Annual accounts 2011227,8 k €↑
2010
Annual accounts 201017,9 k €↓
2009
Annual accounts 2009207,7 k €↓
2008
Annual accounts 2008210,8 k €↑
2007
Annual accounts 200718,6 k €
30/06/2003
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

PHARMASOVA

Overview

What does PHARMASOVA do?

Trend over 19 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline